-
WHEN THE SILENT KILLER SPEAKS LOUDLY: HYPERTENSION'S HIDDEN IMPACT ON WORKERS' COMPENSATION CLAIMS
Aug 11, 2026, 17:16 PM -
COMPARISON OF PATIENT CHARACTERISTICS AND FIRST-LINE TREATMENT PATTERNS IN METASTATIC NSCLC: US AND FINLAND COHORTS TO INFORM OVERALL SURVIVAL TRANSPORTABILITY ANALYSES
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF ONCE-WEEKLY ICOSEMA VERSUS INSULIN ICODEC AND INSULIN GLARGINE U100 FOR TREATING TYPE 2 DIABETES IN ITALY: LONG-TERM ANALYSES USING THE PRIME T2D MODEL BASED ON COMBINE 1 AND COMBINE 4
Aug 11, 2026, 17:16 PM -
QUALITATIVE CONTENT ANALYSIS OF RESPONSES TO THE NICE PUBLIC CONSULTATION ON EXA-CEL FOR THE TREATMENT OF PATIENTS WITH SEVERE SICKLE CELL DISEASE
Aug 11, 2026, 17:16 PM -
WHERE MUST THE HUMAN REMAIN IN THE LOOP? EVALUATING EXPERT-VALIDATION CHECKPOINTS IN AI-ASSISTED HTA EVIDENCE WORKFLOWS
Aug 11, 2026, 17:16 PM -
THE INCIDENCE, MORTALITY, AND SURVIVAL OF MALIGNANT HEPATOCELLULAR CARCINOMA IN THE UNITED STATES: A SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) 2000-2023 DATABASE ANALYSIS
Aug 11, 2026, 17:16 PM -
AI-ENHANCED PHARMACOVIGILANCE COMPLEMENTING RCTS TO ADVANCE THE LANDSCAPE OF SERIOUS ADVERSE EVENTS ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS IN HEPATOCELLULAR CARCINOMA
Aug 11, 2026, 17:16 PM -
EARLY ECONOMIC EVALUATION OF ADJUNCTIVE BLOOD-BRAIN BARRIER MODULATION IN MELANOMA BRAIN METASTASES: A UK NHS PERSPECTIVE
Aug 11, 2026, 17:16 PM -
DEVELOPMENT OF A UK HES-BASED FRAMEWORK TO QUANTIFY ORGANISATIONAL BURDEN IN COMPLEX THORACIC AORTIC REPAIR
Aug 11, 2026, 17:16 PM -
SMALL TRIALS, BIG ASSUMPTIONS: USING MULTILEVEL NETWORK META-REGRESSION TO ADDRESS IMPERFECT RANDOMIZATION IN CLINICAL EVIDENCE NETWORKS
Aug 11, 2026, 17:16 PM -
ECONOMIC EVALUATION OF BIOLOGIC TREATMENT SEQUENCES IN SYSTEMIC LUPUS ERYTHEMATOSUS IN SPAIN
Aug 11, 2026, 17:16 PM -
NATIONAL TRENDS AND ONE-YEAR TRANSITIONS IN FRAILTY AMONG US ADULTS, 2019-2024
Aug 11, 2026, 17:16 PM -
CENOBAMATE VERSUS VAGUS NERVE STIMULATION AND EPILEPSY SURGERY IN FOCAL DRUG-RESISTANT EPILEPSY: A COST-COMPARISON ANALYSIS IN THE UK NHS
Aug 11, 2026, 17:16 PM -
FRAILTY SEVERITY AS A MARKER OF HEALTHCARE NEED ACROSS OUTPATIENT, ACUTE-CARE AND HOME-CARE SETTINGS - A POPULATION-BASED COHORT STUDY OF OLDER ADULTS
Aug 11, 2026, 17:16 PM -
COSTS OF HEALTHCARE RESOURCE UTILIZATION IN INCIDENT CASES OF CHRONIC KIDNEY DISEASE IN PRIMARY CARE: THE REDIC STUDY
Aug 11, 2026, 17:16 PM -
CROSS-NATIONAL CONSISTENCY OF PHYSICAL ACTIVITY AND SLEEP ASSOCIATIONS WITH EPISODIC MEMORY: LONGITUDINAL EVIDENCE FROM FOUR AGING COHORTS
Aug 11, 2026, 17:16 PM -
AN INTEGRATED THREE-PLATFORM AI WORKFLOW FOR EU JOINT CLINICAL ASSESSMENT: AI-ASSISTED PICO DEFINITION, REAL-WORLD EVIDENCE VALIDATION, AND AI DOSSIER AUTHORING
Aug 11, 2026, 17:16 PM -
BEYOND COST-EFFECTIVENESS: PROVIDER-LEVEL SUSTAINABILITY OF ENDOSCOPIC SLEEVE GASTROPLASTY IN SPANISH PRIVATE HOSPITALS
Aug 11, 2026, 17:16 PM -
REAL-WORLD UTILIZATION OF TALAZOPARIB PLUS ENZALUTAMIDE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN THE UNITED STATES
Aug 11, 2026, 17:16 PM -
QUANTIFYING PREFERENCES FOR TYPE 2 DIABETES TREATMENTS AMONGST INDIVIDUALS IN ITALY: A DISCRETE CHOICE EXPERIMENT
Aug 11, 2026, 17:16 PM
